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We have isolated Xenopus p28Kixl, a member of the p21CIPl/p27KIPI /p57KIP2 family of
cyclin-dependent kinase (Cdk) inhibitors. Members of this family negatively regulate cell
cycle progression in mammalian cells by inhibiting the activities of Cdks. p28 shows
significant sequence homology with p21, p27, and p57 in its N-terminal region, where the
Cdk inhibition domain is known to reside. In contrast, the C-terminal domain of p28 is
distinct from that of p21, p27, and p57. In co-immunoprecipitation experiments, p28 was
found to be associated with Cdk2, cyclin E, and cyclin A, but not the Cdc2/cyclin B
complex in Xenopus egg extracts. Xenopus p28 associates with the proliferating cell
nuclear antigen, but with a substantially lower affinity than human p21. In kinase assays
with recombinant Cdks, p28 inhibits pre-activated Cdk2/cyclin E and Cdk2/cyclin A,
but not Cdc2/cyclin B. However, at high concentrations, p28 does prevent the activation
of Cdc2/cyclin B by the Cdk-activating kinase. Consistent with the role of p28 as a Cdk
inhibitor, recombinant p28 elicits an inhibition of both DNA replication and mitosis upon
addition to egg extracts, indicating that it can regulate multiple cell cycle transitions. The
level of p28 protein shows a dramatic developmental profile: it is low in Xenopus oocytes,
eggs, and embryos up to stage 11, but increases -100-fold between stages 12 and 13, and
remains high thereafter. The induction of p28 expression temporally coincides with late
gastrulation. Thus, although p28 may play only a limited role during the early embryonic
cleavages, it may function later in development to establish a somatic type of cell cycle.
Taken together, our results indicate that Xenopus p28 is a new member of the p21/p27/
p57 class of Cdk inhibitors, and that it may play a role in developmental processes.
INTRODUCTION
Progression through the cell cycle is controlled by the
cyclin-dependent kinases (Cdks), which comprise a
family containing various catalytic subunits and reg-
ulatory partners called cyclins. In mammalian cells,
Cdk4/cyclin D, Cdk2/cyclin E, Cdk2/cyclin A, and
Cdc2/cyclin B act sequentially at different points in
the cell cycle (for review, see Draetta, 1993; Sherr,
1993). Although particular details vary, the central
mechanisms of cell cycle regulation by Cdks are con-
served from yeast to vertebrates.
* Corresponding author.
Cdk activities are strictly controlled to ensure that a
cell undergoes cell division cycles only under the ap-
propriate circumstances. The Cdks are regulated by at
least three distinct mechanisms: cyclin binding, sub-
unit phosphorylation, and association with Cdk inhib-
itors. To date, two classes of Cdk inhibitors have been
identified in mammalian cells (for review, see Elledge
and Harper, 1994; Massague and Polyak, 1995). The
pl5/pl6 class includes p15INK4B (Hannon and Beach,
1994), pl6INK4 (Serrano et al., 1993), p18 (Guan et al.,
1994), and p19 (Chan et al., 1995). Proteins in this class
share considerable sequence homology with each
other. They exclusively associate with and inhibit D-
type Cdks, and appear to play a role in cellular differ-
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entiation and tumor suppression (reviewed in Elledge
and Harper, 1994). A second class of Cdk inhibitors
includes p21 (also known as CIP1, WAFi, CAP20, and
SDI1) (El-Deiry et al., 1993; Gu et al., 1993; Harper et al.,
1993; Xiong et al., 1993; Noda et al., 1994), p27KIPI
(Polyak et al., 1994b; Toyoshima and Hunter, 1994),
and p57KIP2 (Lee et al., 1995; Matsuoka et al., 1995). The
N-terminal regions of these three proteins share sig-
nificant homology; this domain can bind to and inhibit
Cdk2/cyclin E, Cdk2/cyclin A, Cdk4/cyclin D, and to
a lesser extent, Cdc2/cyclin B. Although p21 and p27
do not directly inhibit Cdk-activating kinase (CAK),
they can associate with Cdks and prevent them from
being phosphorylated and activated by CAK (Polyak
et al., 1994b; Aprelikova et al., 1995). Except for a
bipartite nuclear localization signal, the C-terminal
domains of these proteins are not strongly conserved:
p21CIPl binds proliferating cell nuclear antigen
(PCNA; a DNA polymerase 6-subunit), while p27KIP1
and p57KIP2 do not (Waga et al., 1994; Chen et al., 1995;
Luo et al., 1995). Moreover, in the central regions,
human p57KIP2 has PAPA repeats while mouse
p57KIP2 has a proline-rich domain followed by acidic
repeats (Lee et al., 1995; Matsuoka et al., 1995). The
structural diversity among p21CIP1, p27KIPl, and
p57KIP2 suggests that these proteins may play distinct
roles in cell cycle regulation.
p21 and p27 participate in diverse regulatory re-
sponses. Following radiation-induced DNA damage,
the tumor suppressor protein p53 up-regulates p21
mRNA levels (El-Deiry et al., 1993). p21 inhibits Cdk2/
cyclin E activity, and thereby prevents DNA replica-
tion (Jackson et al., 1995). Although the C-terminal
domain of p21 associates with PCNA and blocks
PCNA-dependent DNA replication, it does not inhibit
PCNA-dependent DNA repair (Li et al., 1994), giving
irradiated cells the opportunity to remain in Gi and
repair their DNA. Consistent with these observations,
embryonic fibroblasts derived from p21- /- mice are
significantly deficient in their ability to arrest in GI in
response to DNA damage (Deng et al., 1995). Besides
playing a role in the Gl checkpoint, p21 may also be
involved in cellular differentiation under normal cir-
cumstances. For example, p21 mRNA levels increase
in senescent cells (Noda et al., 1994). Also, MyoD, a
skeletal-muscle-specific transcriptional regulator, ac-
tivates the expression of p21 during differentiation in
a p53-independent fashion (Halevy et al., 1995). The
expression pattern of p21 in the mouse correlates with
terminal differentiation and cell cycle withdrawal,
suggesting roles in development (Parker et al., 1995).
However, p21 - / - mice undergo normal development,
and do not develop spontaneous tumors (Deng et al.,
1995), implying the existence of redundant pathways
that ensure proper development and tumor preven-
tion in this organism.
Although the functions of p27 and p57 are less well
understood, they appear to play a role in differentia-
tion-mediated cell cycle arrest and possibly in tumor
prevention. In the mouse, most of the p57-expressing
cells are terminally differentiated (Matsuoka et al.,
1995). The human p57 gene is located at a chromo-
somal region implicated in both sporadic cancers and
a familial cancer syndrome, suggesting that p57 is a
candidate tumor suppressor (Matsuoka et al., 1995).
The regulation of p27 appears to be cell-type depen-
dent. In transforming growth factor (3-arrested or con-
tact-inhibited mink epithelial cells, p27 dissociates
from Cdk4/cyclin D, and binds to and prevents the
CAK-mediated activation of Cdk2/cyclin E (Polyak et
al., 1994a,b). In macrophages, cAMP exerts its anti-
mitogenic effects by raising the level of p27, which
then associates with Cdk4/cyclin D and prevents its
activation by CAK (Kato et al., 1994). During T cell
mitogenesis, interleukin 2 signaling activates Cdk2/
cyclin E complexes by eliminating the p27 protein,
whereas p27 levels fail to drop when the immunosup-
pressant rapamycin is present (Nourse et al., 1994). In
at least some human cell lines, proliferating cells have
a lower level of p27 due to an elevated p27-ubiquiti-
nating activity that targets p27 to the ubiquitin-depen-
dent proteasome degradation pathway (Pagano et al.,
1995).
Although considerable information about Cdk in-
hibitors has emerged recently, much remains to be
learned about the evolution of these families and the
diversity of their functions. Two Cdk inhibitors from
Saccharomyces cerevisiae (the Cdc28/Cln inhibitor Farl
and the Cdc28/Clb2,5,6 inhibitor p40S1c') and one
from Schizosaccharomyces pombe (the Cdc2/Cdcl3 in-
hibitor Ruml) have been identified, but these show
little homology with pl5/pl6 or p21/p27 Cdk inhib-
itors (for review, see Elledge and Harper, 1994). Since
cell-free extracts from Xenopus eggs faithfully recapit-
ulate many cell cycle events including DNA replica-
tion, mitosis, and various checkpoint mechanisms
(Dasso and Newport, 1990; Leno and Laskey, 1991;
Murray, 1991; Minshull et al., 1994; Kumagai and Dun-
phy, 1995), it will be valuable to ascertain the extent to
which Cdk inhibitors contribute to the regulation of
the various Cdks present in this system. Because Xe-
nopus embryos are readily available and easy to ma-
nipulate, Xenopus is also an attractive organism for the
study of developmental regulatory mechanisms. Iso-
lation of Cdk inhibitors from Xenopus and character-
ization of their upstream regulators, downstream tar-
gets, and expression during embryogenesis will
contribute to our understanding of cell cycle regula-
tion and its dynamic changes during development.
With these goals in mind, we have searched for Cdk
inhibitors in Xenopus laevis using a polymerase chain
reaction (PCR)-based approach. Here, we report the
Molecular Biology of the Cell458
Xenopus Cdk Inhibitor
isolation and initial characterization of Xenopus
p28Kixl, a p21/p27-class Cdk inhibitor.
MATERIALS AND METHODS
Cloning of Xenopus p28
An internal fragment of Xenopus p28 was isolated by PCR using
degenerate primers specific to conserved regions among human
p2lCIPl, mouse p21cIP', and human p27KIPI (see Figure 1A). The 5'
primer was (5') CGCGGATCCTG(C/T)(A/C)G(I/C)(I/C)(G/A)(I/
C)(T/C)T(I/C)TT(C/T)GG(I/C)CC(I/C)GT (3'), and the 3' primer
was (5') CGGGGTACCT(G/C)(I/C)IT(I/C)I(G/C)IAA(G/A)TC-
(G/A)AA(A/G)TTCCA (3'). The 5' end of each primer contains
nine extra nucleotides (underlined) to provide restriction sites for
BamHI or KpnI, respectively. PCR reactions (50 ,l) contained 15 ng
of Xenopus oocyte cDNA as template (Mueller et al., 1995) and 50
pmol of each primer. PCR reactions were carried out as described
(Mueller et al., 1995), except that the first five cycles were 94°C for 1
min, 54°C for 2 min, and 72°C for 1 min, and the remaining 30 cycles
were 94°C for 1 min, 57°C for 2 min, and 72°C for 1 min. An
-130-bp DNA fragment was isolated and cloned into the TA clon-
ing vector (Invitrogen, San Diego, CA). After the fragment was
sequenced to confirm its identity, it was radiolabeled by PCR and
used to screen a Xenopus oocyte cDNA library by colony hybridiza-
tion (Sambrook et al., 1989; Mueller et al., 1995). Approximately 1.2
million colonies were screened. Four positives were identified, two
of which encoded the full-length Xenopus p28 gene. The entire
cDNA was sequenced on both strands by primer walking using
Sequenase (United States Biochemical, Cleveland, OH) with the
dideoxy chain termination method. The GenBank accession number
is U38844.
Subcloning of Xenopus p28 into Protein
Expression Vectors
The pAX-NMT plasmid (Mueller et al., 1995) harboring the full-
length Xenopus p28 cDNA was mutagenized by PCR to create an
NdeI site at the initiation codon. Briefly, the 5' primer (5')
GGAAGTCCATATGGCTGCTTTCCACATCGC (3') containing an
NdeI site (underlined) and the 3' primer (5') CTAGATTCGATTG-
GTGCCATGG (3') containing an NcoI site (underlined) were used to
amplify 10 ng of the pAX-NMT-p28 plasmid in the presence of 2.5
U of Pfu DNA polymerase and dNTPs in the buffer supplied by the
manufacturer (Stratagene, La Jolla, CA). The reactions were heated
to 94°C for 2.5 min and 95°C for 0.5 min followed by 20 cycles at
94°C for 1 min, 56°C for 2 min, and 75°C for 5 min. In addition, an
extra 5 min at 75°C was added to the last cycle. After verification by
sequencing, the PCR product was digested with NdeI and NcoI,
generating fragment A (-650 bp), which included the entire coding
region of Xenopus p28. Fragment B (-1 kb) containing the 3'-
untranslated region of Xenopus p28 was obtained by digesting Xe-
nopus p28 in the pBlueScript vector (Stratagene) with Ncol and
EcoRI. Finally, the bacterial expression vector pET9-His6 (Kumagai
and Dunphy, 1995) and the insect cell expression vector pVL1393-
His6 (Tang et al., 1993) were digested with NdeI and EcoRI, and were
ligated with fragments A and B through a three-piece ligation. The
resulting plasmids pET9-His6-p28 and pVL1393-His6-p28 were
used for production of recombinant proteins. Sequence alignments
were performed using the PILEUP program.
Antibody Production
Rabbits were immunized either with a C-terminal peptide from
Xenopus p28 (CPLEQTPRKKIR) coupled to keyhole limpet hemocy-
anin or with purified Xenopus p28 protein expressed in bacteria (see
below). Anti-peptide antibodies were affinity-purified on Affi-Gel 10
columns (Bio-Rad, Hercules, CA) containing covalently attached
peptides. Anti-p28 protein antibodies were affinity purified on pu-
rified p28 protein coupled to CNBr-activated Sepharose 4B columns
(Pharmacia Biotech, Uppsala, Sweden). Affinity-purified anti-Xeno-
pus cyclin El antibodies and anti-Xenopus Cdk2 antibodies were a
generous gift from J. Maller (University of Colorado, Denver, CO).
Purified monoclonal anti-human PCNA antibodies and polyclonal
rabbit anti-human p21 antibodies were purchased from PharMin-
gen (San Diego, CA). Affinity-purified rabbit anti-mouse IgG anti-
bodies were purchased from Cappel (West Chester, PA). Antibodies
to Xenopus Cdc2, cyclin Al, and cyclin B2 were generously provided
by A. Kumagai (Kumagai and Dunphy, 1995; our unpublished
results).
Production and Purification of Proteins from Insect
Cells and Bacteria
The pET9-His6-p28 and pET3d-His6-human p21 (Xiong et al., 1993)
plasmids were transformed into BL21(DE3)pLysS bacteria. The bac-
teria were grown to mid-log phase and then induced, harvested,
and lysed as described (Kumagai and Dunphy, 1991). The lysates
were clarified and the p28 protein was purified by nickel-IDA
Sepharose chromatography (Kumagai and Dunphy, 1995). In the
case of Xenopus p28, the protein was further purified using SDS-
PAGE followed by electro-eluting in an Elutrap (Schleicher &
Schuell, Keene, NH). The pure protein was used to produce rabbit
anti-Xenopus p28 protein antibodies.
Histidine-tagged Xenopus p28, histidine-tagged human cyclin BI
(Kumagai and Dunphy, 1995), and histidine-tagged human cyclin A
and cyclin E (Desai et al., 1992; Koff et al., 1992) were purified from
insect cell lysates using established protocols (Desai et al., 1992).
Xenopus Cdc2- or human Cdk2-containing lysates were aliquoted,
drop frozen in liquid nitrogen, and stored at -80°C. 35S-labeled
His6-p28 was purified from metabolically labeled insect cells using
a standard protocol (Kumagai and Dunphy, 1995).
In Vitro Cdk Inhibition Assays
Active Cdk2/cyclin A, Cdk2/cyclin E, and Cdc2/cyclin B com-
plexes were prepared essentially as described previously (Kumagai
and Dunphy, 1995). Briefly, 20 ,ul of histidine-tagged cyclins bound
to nickel-IDA beads were agitated with 100 ,ul of Cdk2- or Cdc2-
containing insect cell lysates in the presence of 0.5 mM ATP and 10
mM MgCl2 for 20 min at room temperature. The beads were then
washed four times with ice-cold HBS (150 mM NaCl, 10 mM N-2-
hydroxyethylpiperazine-N'-2-ethanesulfonic acid, pH 7.5), and
eluted with 20 ,ul of 300 mM imidazole in HBS. All kinase assays
were performed in the linear range. Kinase complexes were mixed
with increasing amounts of Xenopus p28 or human p21, preincu-
bated on ice for 5 min, and finally histone Hl assays were per-
formed as described in Dunphy and Newport (1989). To assess the
effect of Xenopus p28 on the activation of the Cdc2/cyclin B complex
in insect cell lysates, increasing amounts of p28 were incubated with
Cdc2-containing insect cell lysates (2 ,ul) and purified cyclin B (0.3 ,ul)
at room temperature for 20 min, and the histone HI kinase activity was
measured. Quantitation of kinase assays was performed with a Phos-
phorlmager (Molecular Dynamics, Sunnyvale, CA).
Preparation of Extracts from Xenopus Eggs,
Embryos, Oocytes, and Tissue Culture Cells
Xenopus cytostatic factor (CSF)-arrested egg extracts were prepared
as described by Murray (1991). Interphase extracts were obtained by
activation of CSF extracts with 0.4 mM CaCl2. Freshly squeezed
eggs were fertilized in vitro to obtain synchronously developing
embryos (Newport and Kirschner, 1982a). Embryos were main-
tained in 0.2x MMR (Murray, 1991) for the first 6 h, and in 0.1>X
MMR thereafter. Embryos were staged according to the method of
Nieuwkoop and Faber (1967). Typically, 20 embryos were homog-
enized in 200,ul of ice cold EB (80 mM ,3-glycerol phosphate, pH 7.3,
20 mM EGTA, and 15 mM MgCl2) containing 1 mM dithiothreitol,
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and 10 ,tg/ml each of pepstatin, chymostatin, and leupeptin (PCL).
The homogenate was clarified by centrifugation at 16,000 X g for 5
min at 4°C. The crude cytoplasmic fraction was aliquoted and drop
frozen in liquid nitrogen. Oocytes were separated from ovary tissue
by treatment with collagenase (Cyert and Kirschner, 1988). Oocytes
at different stages were manually selected and homogenized as
described above for embryos. Xenopus tissue culture (XTC) cells
were cultured using standard methods (Smith and Tata, 1991).
Proliferating cells were harvested, and cell pellets were dissolved in
SDS gel sample buffer.
Immunoprecipitation and Western Blotting
Affinity-purified anti-p28 protein antibodies (2 Ag) or control rabbit
anti-mouse IgG antibodies (2 ,g) were incubated with protein A
beads (Sigma, St. Louis, MO) in HBS for 1 h at 4°C. In the case of p21
immunoprecipitation, 2 ,ul of rabbit anti-human p21 antibodies were
used. The antibody-coated beads were then incubated with mitotic
extracts or interphase extracts for 1 h at 4°C. In some cases, recom-
binant p28 was added to the extracts, and in these experiments,
cycloheximide was also included. Following incubation with the
extracts, the beads were collected by centrifugation and washed
four times with EB containing 0.1% NP-40, 25 ,ug/ml aprotinin, 1
mM phenylmethylsulfonyl fluoride, 1 mM benzamidine, and 10
,ug/ml PCL, and then three times with HBS. All washes were done
at 4°C. Similar washes were carried out for nickel-IDA beads recov-
ered from the extracts (which had been diluted two-fold in EB
containing PCL). To recover p28 using p13 beads, CSF extracts were
incubated with a 25% volume of p13 beads (5 mg p13/ml beads) or
control beads lacking p13 for 1 h at 4°C. Beads were removed by
centrifugation, and the extracts were re-incubated with fresh beads.
The p13 beads or the control beads were pooled, and washed as
described for protein A beads. Immunoblotting using 1251I-labeled
protein A (ICN, Irvine, CA) or 251I-labeled sheep anti-mouse IgG
antibodies (Amersham, Arlington Heights, IL) was performed as
described (Coleman et al., 1993). Alternatively, ECL (Amersham)
was performed using horseradish peroxidase-conjugated goat anti-
rabbit IgG antibodies (Bio-Rad).
Replication Assays
Replication assays were performed essentially as described previ-
ously (Dasso and Newport, 1990). Briefly, 40 ,ul of CSF extracts
containing 100 ,tg/ml cycloheximide, 10 ,uCi [a-32P]dCTP (ICN),
and demembranated sperm nuclei (500 per ,ul) were incubated with
10 ,ld of Cdk inhibitors for 5 min at room temperature before
activation with CaCl2. At various time points, 3-,ul aliquots were
taken, mixed with replication sample buffer, and frozen at -20°C.
The samples were digested with proteinase K (Boehringer Mann-
heim, Mannheim, Germany) and separated on a 0.8% agarose gel.
Quantitation was performed using a Phosphorlmager (Molecular
Dynamics).
RESULTS
Isolation of Xenopus p28
To search for Cdk inhibitors from Xenopus laevis, we
designed degenerate PCR primers based upon con-
served residues in the Cdk inhibition domain of hu-
man and mouse p2lclp as well as human p27KIP1
(Figure 1A). PCR amplification of Xenopus oocyte
cDNA yielded a -130-bp fragment, which was used
to isolate the corresponding full-length cDNA from an
oocyte library. Several positive clones were identified;
the longest (-1.7 kb) encodes a protein of 209 amino
acids with a predicted molecular weight of 23,460 Da
(Figure 1A). Since the endogenous protein in Xenopus
extracts migrated at 28 kDa during SDS gel electro-
phoresis (see below), we have designated this protein
as p28Kxl' (for cyclin-dependent kinase inhibitor from
Xenopus).
The N-terminal region of p28 is 35% identical to
p21/p27-class Cdk inhibitors (Figure 1A). The most
noticeable conservation is within the Cdk inhibition
domain (the hatched box in Figure 1B; residues 30-90
in p28), which in the cases of p21, p27, and p57, is
sufficient to bind and inhibit Cdks (Polyak et al., 1994b;
Luo et al., 1995). The C-terminal regions of p28, p21,
and p27/p57 are less well conserved (21-25% identi-
cal), but they all have a putative nuclear localization
signal. In the case of p28, residues 166-182 (KREIT-
TPITDYFPKRKK; the black box in Figure 1B) fit the
consensus for the bipartite nuclear localization signal
first found in nucleoplasmin (Dingwall and Laskey,
1991). Moreover, p28 has several Ser/Thr-Pro motifs
(stars in Figure 1B) that are potential sites for phos-
phorylation by various mitotic kinases. Recently, Su et
al. (1995) have cloned a distinct Xenopus Cdk inhibitor
(Xicl) that is 90% identical to Kixl at the amino acid
level, indicating that multiple genes for Cdk inhibitors
are expressed in this organism.
Recombinant p28 Can Inhibit Cdks via
Two Mechanisms
To characterize its biochemical properties, p28 was
expressed as a histidine-tagged fusion protein in bac-
ulovirus-infected insect cells, and purified using nick-
el-IDA affinity chromatography (Figure 2). His6-p28
migrated with an apparent molecular weight of 28
kDa, slightly larger than the endogenous Xenopus p28
(see Figure 6A).
Because p28 possesses a Cdk inhibition domain sim-
ilar to that of other p21/p27 Cdk inhibitors, we exam-
ined whether p28 could inhibit various recombinant
Cdk complexes. In particular, the effect of p28 upon
Cdk2/cyclin E, Cdk2/cyclin A, and Cdc2/cyclin B
was examined. Active Cdk complexes were prepared
by mixing insect cell lysates containing the individual
Cdk components under conditions that allowed for-
mation of the complex and its activation by an endog-
enous insect cell CAK. After Cdk complexes were
purified by nickel-IDA chromatography and mixed
with either human p21 or Xenopus p28, their activities
were measured with histone HI as the substrate (Fig-
ure 3A). As expected, p21 inhibited Cdk2/cyclin E in
a dose-dependent manner (Figure 3, A and B). In
parallel experiments, p28 effectively inhibited the ki-
nase activity of both Cdk2/cyclin E and Cdk2/cyclin
A when present in only a fivefold molar excess of the
Cdk (Figure 3, A and B). In contrast, p28 displayed
little inhibitory activity toward Cdc2/cyclin B even at
molar concentrations -800-fold higher than the Cdk
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complex. Finally, like p21 and p27, Xenopus p28 is heat
stable: heating p28 to 100°C for 5 min had little effect
upon its capacity to inhibit Cdk2/cyclin E (Figure 3C).
Taken together, these data suggest that p28 is a Cdk
inhibitor with a striking preference for the Gl /S Cdks
over the mitotic Cdk in these in vitro assays.
In addition to directly inhibiting Cdk activity, both
the p21/p27 and pl5/p16 classes of inhibitors have
been observed to exert their effects by preventing
CAK-mediated activation of Cdks (Polyak et al., 1994b;
Aprelikova et al., 1995). To investigate the possibility
that p28 might have a similar function, we added p28
during the step at which the active Cdk complex was
prepared. Although p28 did not inhibit pre-activated
Cdc2/cyclin B, it nevertheless blocked the formation
of the activated Cdc2/cyclin B complex. At a concen-
tration of 160 nM, p28 elicited a 90% reduction in the
Hi kinase activity generated by mixing insect cell
lysates containing Cdc2 and cyclin B (Figure 3D). This
inhibition coincided with a reduction in the level of
the threonine-161-phosphorylated (active) form of
Cdc2 (our unpublished results), indicating that p28
can interfere with CAK-mediated activation of Cdc2/
cyclin B.
p28 Associates with Cyclin-dependent Kinases in
Xenopus Extracts
Having characterized the effect of p28 upon recombi-
nant Cdks, we examined whether p28 might associate
with any of these Cdks in Xenopus egg extracts. As an
initial method to monitor the association of p28 with
Cdks in egg extracts, we utilized p13-agarose beads,
an affinity matrix that binds Cdc2, Cdk2, and associ-
ated proteins. p28 was recovered efficiently by p13
beads but not control beads (Figure 4A), suggesting
that endogenous p28 is associated with Cdks in egg
extracts. To identify which Cdks associate with p28,
we immunoprecipitated p28 from egg extracts with
anti-p28 whole protein antibodies, and subsequently
subjected the immunoprecipitates to immunoblotting
with various antibodies. Cyclin El and cyclin Al (Fig-
ure 4B), but not cyclin B2, co-immunoprecipitated
with p28. We also probed the immunoprecipitates
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Figure 1. Xenopus p28 belongs to the p2CIPl /p27KIPI Cdk inhibitor family. (A) Sequence alignment of Xenopus p28, human p27KI l, and
human p2lCIPl. Boxes indicate identical residues shared by two or more sequences. Arrows mark sequences that were used to design
degenerate PCR primers. (B) Schematic diagram of the domain structure of Xenopus p28. The CDK inhibition domain (hatched box) is
conserved among Xenopus p28, human and mouse p21CIPl, p27KIPI, and p57KIP2 A putative bipartite nuclear localization signal (black box)
and several potential kinase phosphorylation sites (stars) are indicated. Numbers indicate amino acid residues.























Figure 2. Purification of recombi-
nant Xenopus p28. Recombinant
His6-p28 was expressed in Sf9 in-
sect cells and purified using nickel-
IDA chromatography. Purified
His6-p28 (lane 1) and molecular
markers (lane 2) were run on a
12.5% SDS gel, and stained with
Coomassie brilliant blue.
with anti-p28 antibodies to monitor the endogenous
p28 protein (Figure 4B). Using recombinant p28 as a
standard, we estimated that p28 was present at a
rather low concentration (0.05 ng/Al, or 2 nM) in
Xenopus egg extracts (our unpublished results). In con-
trol experiments with 35S-labeled p28, we verified that
the anti-p28 antibodies immunoprecipitated p28
quantitatively under these conditions. In accompany-
ing studies, recombinant p28 was incubated with ex-
tracts, and then immunoprecipitated (Figure 4C). Im-
munoblotting of these immunoprecipitates revealed a
significant association of p28 with cyclin El and Cdk2,
but not cyclin B2. In addition, only small amounts of
Cdc2 (perhaps complexed with cyclin Al or A2) were
detected in the anti-p28 immunoprecipitates.
Next, we tested whether p28 was modified during
the cell cycle, and if so, whether this could affect its
association with Cdks. Radiolabeled recombinant p28
was incubated with either mitotic or interphase ex-
tracts. The electrophoretic mobility of p28 incubated in
mitotic extracts was reduced compared with p28 from
interphase extracts (Figure 4D). Furthermore, the up-
shifted form of p28 could be shifted down by protein
phosphatase 2A (our unpublished results), suggesting
that certain kinase(s) in mitotic extracts can phosphor-
ylate p28. Although p28 was differentially phos-
phorylated during the cell cycle, its association with
Cdk complexes did not vary discernibly (Figure 4, B
and C).
The C-terminal domain of human p21 associates
with the replication and repair factor PCNA (Waga et
al., 1994; Chen et al., 1995; Luo et al., 1995). To deter-
mine whether p28 could bind PCNA, equivalent
amounts (0.12 ,ug) of recombinant p28 or human p21
(as a positive control) were added to extracts, immu-
noprecipitated with their respective antibodies, and
immunoblotted with anti-human PCNA antibodies,
which cross-react well with Xenopus PCNA. As antic-
ipated, anti-human p21 antibodies immunoprecipi-
tated PCNA. In contrast, PCNA was not readily de-
tected in anti-p28 immunoprecipitates (Figure 4E),
suggesting that either p28 does not bind to PCNA or it
binds more weakly than human p21. To explore this
issue further, approximately 40-fold more recombi-
nant p28 was added to the Xenopus extracts, and was
later recovered with nickel-IDA beads. We observed
that p28 could associate with PCNA under these con-
ditions, but the amount of PCNA bound to 5 ,g of p28
was less than that bound to 0.7 ,ug of p21 (Figure 4E).
Thus, p28Kil , like the recently described Xicl protein
(Su et al., 1995), can associate with PCNA, but not
nearly as efficiently as human p21.
p28 Inhibits Chromosomal Replication and Mitosis
in a Dose-dependent Manner
To explore further the functional properties of p28, we
added recombinant p28 to cell cycle extracts from
Xenopus eggs (Murray, 1991). Upon activation with
Ca2+, CSF-arrested mitotic egg extracts enter inter-
phase, undergo a complete round of semi-conserva-
tive DNA replication, and enter mitosis shortly there-
after. Tracer radiolabeled p28 was found to be stable
in extracts throughout the duration of such experi-
ments.
We first asked whether p28 would affect chromo-
somal DNA replication, which is known to require
Cdk2/cyclin E activity (Jackson et al., 1995). Using
[a-32P]dCTP as a tracer, the extent of DNA replication
was assessed at various time points after Ca2 activa-
tion. In control extracts treated with buffer only, rep-
lication commenced between 30 and 45 min after Ca +
addition, and was essentially complete by 120 min
(Figure 5A). However, in extracts containing added
p28, there was a strong inhibition of DNA replication
(Figure 5A). At the highest concentration of p28 tested
(1.6 t,M), there was essentially no replication within
the first 90 min. At later times, even though a small
amount of replication took place, it clearly occurred at
a substantially reduced rate relative to the control
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Figure 3. Xenopus p28 exhibits differential
inhibitory activities toward various Cdk
complexes. (A) Pre-activated Cdk2/cyclin A
(lanes 1-5), Cdc2/cyclin B (lanes 6-10), and
Cdk2/cyclin E (lanes 11-15) were incubated
with the indicated amounts of p28. As a
control, pre-activated Cdk2/cyclin E was
also incubated with the indicated amounts
of human p2lCIP" under identical conditions
(lanes 16-21). The HI kinase activities of the
Cdks were then measured. (B) Hi kinase
activities in panel A were quantitated, and
are plotted as the percentage of kinase ac-
tivity in the absence of inhibitors. (C) p28 is
heat stable. HI kinase activities of Cdk2/
cyclin E complex (16 nM) in the presence of
control buffer (lane 1), native p28 (80 nM,
lane 2), or p28 that had been boiled at 100°C
for 5 min (80 nM, lane 3) were assayed. (D)
p28 inhibits Cdc2/cyclin B activation. Cdc2-
containing insect cell lysates were incubated
at room temperature with purified cyclin B
in the presence of either control buffer (lane
1) or p28 (40 nM, lane 2; 160 nM, lane 3). The






























extracts. A similar phenomenon was observed in ex-
tracts supplemented with the same amount of human
p21 (Figure 5A). At lower concentrations of p28, the
onset of replication was delayed in a dose-dependent
fashion (Figure 5, A and B). In particular, replication
commenced at 90 min and 60 min at p28 concentra-
tions of 800 nM and 320 nM, respectively. Interest-
ingly, once replication began, it proceeded at a similar
rate to that in the control extracts. This observation
might suggest that at lower concentrations ('800 nM),
p28 has a preferential effect on initiation versus elon-
gation, whereas at higher concentrations, both pro-
cesses are compromised. Finally, because chromo-
somal replication in egg extracts requires that the
DNA be properly assembled into a nuclear structure,
we verified by phase and fluorescence microscopy
that the control and inhibitor-treated extracts were
equally competent for nuclear assembly (our unpub-
lished results).
We also examined whether recombinant p28
could affect the entry into mitosis in extracts con-
taining a very low concentration of sperm chroma-
tin (25 demembranated sperm nuclei per microliter
of extract). It has been shown previously that this
concentration of sperm nuclei is below the threshold
necessary to trigger the replication checkpoint
(Dasso and Newport, 1990). These extracts allow a
direct assessment of the effect of p28 on mitosis
independent of its effect on replication. Intriguingly,
we observed that p28 elicited a dose-dependent de-
lay of mitosis relative to control extracts (Figure
6A). At a concentration of 800 nM, p28 delayed
mitosis by approximately 60 min. In parallel, we
examined the effect of p28 (800 nM) on total Hi
kinase activity during the cell cycle in egg extracts
(Figure 6B). As expected, p28 suppressed the rise in
Hi kinase activity that occurred in the control ex-
tracts at 90 min. Significantly, exogenously added
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C g Figure 4. p28 associates with Cdks in Xe-
q Q. A, nopus egg extracts. (A) M-phase extracts
dtabc s vr (160 ,ul) were rotated with p13 (lane 1) or
Q 0 control (lane 2) agarose beads. The beadsC" ¢@>were then washed and immunoblotted
with anti-p28 peptide antibodies. (B) Mi-t t t s 4 4 totic (M-phase) extracts (300 ,ul, lanes 3
and 4) and interphase (I-phase) extracts
(300 ,ul, lanes 5 and 6) were immunopre-
--- Cdk2 cipitated with anti-Xenopus p28 whole
protein antibodies (lanes 3 and 5) or with
control rabbit anti-mouse IgG antibodies
(lanes 4 and 6). The total immunoprecipi-
tates or M-phase and I-phase extracts (2
,ul, lanes 1 and 2, respectively) were
probed with antibodies against Xenopus
<---- Cdc2 cyclin El, cyclin Al, and p28 as indicated.
(C) Recombinant p28 (10 ng) was added to
100 ,ul of M-phase (lanes 2 and 3) or I-
phase (lanes 5 and 6) extract. The total
anti-p28 immunoprecipitates (lanes 2 and
fcNin El 5) and mock immunoprecipitates (lanes 3and 6) from these extracts or 2 ,ul of M-
- _ -- cyclin El phase and I-phase extract (lanes 1 and 4,
respectively) were subsequently probed
rclin Al with antibodies against Xenopus Cdk2,
Cdc2, cycin El, and cyclin B2 as indicated.
(D) 35S-labeled p28 was added to M-phase
(lane 1) and I-phase (lane 2) extracts. The
8
cyclin B2 slower-migrating form in lane 1 corre-8 sponds to the phosphorylated p28. (E)
Lanes 2-5: the indicated amounts (in ,tg)
of His6-p28 or His6-p21 were added to
1 2 3 4 5 6 M-phase extracts (50 ,ul), and immunopre-
cipitated with anti-Xenopus p28 (lane 2), or
anti-human p21 (lane 4) antibodies, or
mock-precipitated (m) with control rabbit
.12 .12 0 0 0 5 0 anti-mouse IgG antibodies (lanes 3 and 5).
0 0 .12 .12 0 0 0.7 Lanes 6-8: nickel-IDA beads and the in-dicated amounts (in ,ug) of His6-p28 or
E) p28 m p21 m (E) His6-p21 were incubated in 200 [lI of two-fold diluted M-phase extract, and the
beads were then recovered. The immuno-
41mm -~- PCNA precipitates, the nickel-IDA beads, or M-
phase extracts (E) (0.5 j.d, lane 1; 1 ,ul, lane
9) were probed with anti-human PCNA
1 2 3 4 5 6 7 8 9 antibodies.
p28 also depressed the level of Hi kinase activity at
early times in the cell cycle (i.e., 30 min) when
relatively little active Cdc2/cyclin B would be ex-
pected to be present. This effect could be due to
inhibition of the Cdk2/cyclin E complex, which
shows significant activity throughout the early em-
bryonic cell cycles (Rempel et al., 1995), or, alterna-
tively, another unidentified Cdk. Taken together,
our results indicate that at sufficiently high levels,
not only does p28 abolish DNA replication, it also
strongly inhibits entry into mitosis.
The Abundance of p28 Varies during Development
The abundance of p28 in Xenopus eggs is approxi-
mately 2 nM, whereas the concentration of recom-
binant p28 required to either inhibit recombinant
Cdks in vitro or affect cell cycle progression in egg
extracts is approximately 100-fold higher. To eval-
uate this paradox, we asked whether p28 might be
expressed at higher levels during later stages of
development when dividing cells acquire an ex-
tended Gl phase or withdraw from the cell cycle.
For this purpose, extracts from oocytes, eggs, stage
26 embryos, and somatic XTC cells were immuno-
blotted with antibodies directed toward a C-termi-
nal peptide of Xenopus p28. Although the level of
p28 was similarly low in oocytes and mature eggs
(-2 nM), it was approximately 100-fold higher in
stage 26 embryos and XTC cells where the "somat-
ic" cell cycle has replaced the "embryonic" one
(Figure 7A). To pinpoint more precisely at what
stage during development p28 begins to be up-




regulated, embryonic lysates were prepared at finer
time points. The level of p28 remained low through-
out the blastula and early gastrula stages. However,
it increased dramatically between stages 12 and 13,
and by stage 14, it had peaked to a level that re-
mained relatively constant until at least stage 26
(Figure 7B; our unpublished results). The up-regu-
lation of p28 occurs at -5 h after the commence-
ment of gastrulation, a time corresponding most
closely to the small yolk plug stage and the slit-
blastopore stage when the neural plate first becomes
discernible.
To verify that the protein detected in these experi-
ments is Xenopus p28, a peptide-competition experi-
ment was carried out (Figures 7C). Immunoblots con-
taining recombinant p28 and stage 26 embryonic
lysates were treated with anti-p28 antibodies in the
presence or absence of the immunizing peptide. The
staining of both recombinant and embryonic p28 was
abolished by the peptide, whereas that of a back-
ground band was unaffected. Taken together, these
experiments indicate that the expression of p28 in-
creases as cells acquire a somatic type of cell cycle.
A b
DISCUSSION
To study the potential regulation of the cell cycle by
Cdk inhibitors in Xenopus egg extracts, we have iso-
lated Xenopus p28, a new member of the p21CIP1/
p27KIPI /p57KIP2 family of Cdk inhibitors. The Cdk
inhibition domain of p28 shows significant sequence
homology to those of p21, p27, and p57. Indeed, p28
effectively inhibits pre-activated Gl/S Cdks, such as
Cdk2/cyclin E and Cdk2/cyclin A, while exhibiting
little inhibitory activity toward the mitotic Cdc2/cy-
clin B complex in vitro, like some other members of
the family (Harper et al., 1995; Lee et al., 1995). Con-
sistent with this observation, Cdk2, cyclin A, and cy-
clin E in egg extracts can be co-immunoprecipitated
with p28, whereas the Cdc2/cyclin B complex appears
not to be stably associated with p28.
It has been shown previously that Cdk inhibitors in
the p21 /p27/p57 class are also able to block the phos-
phorylation and activation of Cdks by CAK without
directly binding to CAK or inhibiting CAK activity
(Harper et al., 1993, 1995; Polyak et al., 1994b; Apre-
likova et al., 1995; Matsuoka et al., 1995). p28 has
buffer 1.6 jM p28 1.6 .M p21 800nM p28
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Figure 5. Xenopus p28 inhibits chromosomal
replication in a dose-dependent manner. (A)
CSF-arrested extracts (500 sperm nuclei/,ul, 0.2
,tCi [a_-32P]dCTP/ttl) were incubated with buffer
(lanes 1-6), Xenopus p28 (1.6 t,M, lanes 7-12; 0.8
,uM, lanes 19-24), or human p2lCIPI (1.6 ,uM,
lanes 13-18). The extracts were then activated by
CaCl2, and at the indicated time points, samples
were taken to assay the extent of replication by
monitoring the total incorporation of [32P]dCTP
into DNA. (B) Quantitation of various replication
assays in arbitrary units (including those pre-
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similar properties. In particular, p28 does not bind to
recombinant human CAK (our unpublished results),
nor does it inhibit the kinase activity of CAK toward
the C-terminal peptide of RNA polymerase II (our
unpublished results). However, p28 prevents Cdc2/
cyclin B activation by CAK, suggesting that despite
the apparent preference for Gl /S Cdks, p28 could
down-regulate mitotic Cdk activities through preven-
tion of CAK-mediated activation. It seems paradoxical
that p28 has little affinity for Cdc2/cyclin B or CAK,
yet it is able to prevent the latter from activating the
former. One possible explanation is based on the ob-
servation that multiple molecules of p21 are required
to inhibit Cdks and that complexes containing a single
p21 molecule are active (Zhang et al., 1994). Thus, it is
possible that a single molecule of p28 could bind the
Cdc2/cyclin B complex to block CAK-mediated acti-
vation, whereas multiple molecules of p28 could not
efficiently associate with and inhibit the pre-activated
complex. Alternatively, the off-rate of p28 from
Cdc2/cyclin B and/or CAK might be fast so that the
kinase-inhibitor complexes do not survive successive
washing steps in our binding assays. p28 would pre-
sumably also inhibit the CAK-mediated activation of
Cdk2/cyclin E and Cdk2/cyclin A, since it has a
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Figure 6. Xenopus p28 inhibits mitosis in a dose-dependent man-
ner. (A) CSF extracts (containing 25 sperm nuclei/,ul extract) were
mixed with various amounts of Xenopus p28 protein and then
activated. Entry into mitosis was scored visually and was defined as
the time point where 50% of the nuclear envelopes had broken
down relative to buffer-treated extracts. (B) HI kinase activities of a
CSF extract (lane 1) or activated extracts containing either p28 (800
nM, lanes 2-7) or control buffer (lanes 8-13) were measured at the
indicated times after Ca2+ addition. The p28-treated and the control
extracts entered mitosis at 150 min and 90 min, respectively.
We also analyzed the biochemical functions of p28
by adding recombinant p28 to Xenopus egg extracts.
Cdk2/cyclin E activity is required for the initiation of
chromosomal DNA replication in this system (Jackson
et al., 1995). In egg extracts, the concentration of cyclin
El is -60 nM (Rempel et al., 1995). At a fivefold molar
excess above cyclin El, p28 elicited a readily observ-
able delay in the onset of replication, consistent with
the observed inhibitory effects of p28 on recombinant
Cdk2/cyclin E complex. Intriguingly, although there
was a delay in the onset of DNA synthesis, once
replication began, it proceeded at a rate comparable to
that in control extracts. At higher levels of p28, both
the rate and the overall extent of DNA replication
were severely inhibited. These findings could argue
that although p28 preferentially inhibits initiation as
opposed to elongation, at higher concentrations, p28
could inhibit elongation as well. An alternative possi-
bility would be that when the level of p28 is high,
some replication origins could fire late, giving rise to
an extended S phase reminiscent of the somatic cell
cycle (for review, see Fangman and Brewer, 1992).
Finally, p28 could block initiation of some replication
origins, possibly by preventing the transition from
pre-replicative foci to initiation complex, a phenome-
non previously observed when high levels (1-2,uM) of
human p21 were added to extracts (Jackson et al., 1995;
Yan and Newport, 1995). Further mechanistic studies
will be required to evaluate these possibilities.
We have observed that p28 also elicits a dose-de-
pendent delay of mitosis. In principle, this mitotic
delay could result from the replication checkpoint re-
sponding to p28-dependent inhibition of DNA synthe-
sis. However, we feel that this explanation is not likely
because p28 elicits a mitotic delay even in the presence
of a concentration of sperm chromatin (25 sperm/,ul of
extract) well below the threshold required to trigger
the replication checkpoint in this system (Dasso and
Newport, 1990). One explanation is that p28 delays
mitosis by inhibiting the CAK-mediated activation of
Cdc2/cyclin B, which would be consistent with the
ability of p28 to block the activation of Cdc2/cyclin B
in insect cell lysates. Alternatively, it is conceivable
that p28 could be a more potent inhibitor of the en-
dogenous Cdc2/cyclin B in egg extracts than the pu-
rified recombinant Cdc2/cyclin B. Finally, it could be
that cyclin El- and/or cyclin A-associated kinase ac-
tivities play an additional essential role in mitosis, and
that by inhibiting the kinase activities associated with
these cyclins, p28 impedes the entry into mitosis.
An important characteristic of human p21 is that it
can form a stable complex with the replication factor
PCNA. The PCNA-interacting domain of p21 has been
mapped to the peptide QTSMTDFY (residues 144-
151) (Warbrick et al., 1995). The three residues that
contribute the most to PCNA binding in p21 (Q144,
M147, and F150) are not conserved in Xenopus p28Kixl
Molecular Biology of the Cell466
Xenopus Cdk Inhibitor
or Xicl (Su et al., 1995), which could account for the
observation that PCNA binds Xenopus p28 much less
well than it binds human p21. Human and mouse p27
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Figure 7. Xenopus p28 is developmentally regulated. (A) A com-
parison of p28 protein levels during Xenopus development. His6-p28
(10 ng, lane 1) and extracts made from stage IV or earlier oocytes
(100 ,tg, lane 2), stage V/VI oocytes (100 ,ug, lane 3), CSF-arrested
eggs (100 ,ug, lane 4), stage 26 embryos (60 ,ug, lane 5), and XTC cells
(60 ,ug, lane 6) were immunoblotted with anti-p28 peptide antibod-
ies. (B) The p28 protein level is elevated during stages 12 and 13.
One nanogram of His6-p28 (lane 1), 100 ,tg of CSF extract (lane 2),
and 60 jig of extract made from embryos at the indicated stages
(lanes 3-11) were immunoblotted with anti-p28 peptide antibodies.
(C) Peptide-blocking assay. Identical strips containing His6-p28 and
stage 26 embryo extracts were immunoblotted with anti-p28 pep-
tide antibodies (400 ng/ml) in the absence (left panel) or presence
(right panel) of the p28 C-terminal peptide (200 ng/ml). All blots
were visualized using ECL.
1995), raising the possibility that Xenopus p28 may
belong to the mammalian p21 subfamily. However,
the C-terminal domain of p28 does contain a QT motif
(LEQTPRK, residues 200-206) that is found in mam-
malian p27 and p57 (see Matsuoka et al., 1995). Thus,
further characterization of p28 will be required to
classify this Cdk inhibitor definitively.
p28 is present at low levels in oocytes, mature eggs,
and embryos up to stage 11. During this period, its
concentration is -2 nM, well below the concentration
of 60 nM at which its preferred target, cyclin El, is
present (Rempel et al., 1995). The next best candidate,
namely cyclin Al, is also more abundant (18 nM-60
nM) than p28 in Xenopus eggs (Rempel et al., 1995).
Although it is conceivable that p28 might regulate a
Cdk distinct from cyclin El and cyclin Al, a more
plausible scenario is that p28 does not play a rate-
limiting role in controlling the onset of replication or
mitosis during early embryogenesis. This notion
would be consistent with the fact that the early em-
bryonic cleavages occur very rapidly (i.e., approxi-
mately every 35 min) without any discernible gaps
between S-phase and M-phase. The midblastula tran-
sition (stage 81/2) defines the first developmental event
where the cell cycles in certain embryonic cells begin
to slow down and become asynchronous with respect
to one another (Newport and Kirschner, 1982a). This
transition also coincides with the commencement of
zygotic transcription (Newport and Kirschner, 1982b).
Later, at stage 10, another major transition occurs dur-
ing early gastrulation. This early gastrulation transi-
tion is marked by the elimination of maternal mRNAs
for cyclins Al and A2 (Howe et al., 1995). In parallel,
the amount of cyclin Al protein drops precipitously to
undetectable levels, whereas the level of cyclin A2
protein translated from zygotic cyclin A2 mRNA in-
creases dramatically (Howe et al., 1995; see also Rem-
pel et al., 1995). The level of Xenopus p28 protein
remains low at both the midblastula transition and
early gastrulation transition, but it does increase dra-
matically at a significantly later time, namely during
stages 12 and 13. In principle, the up-regulation of p28
at stages 12 and 13 could mark another developmental
transition at late gastrulation in the Xenopus embryo.
Alternatively, the increase in the levels of p28 could
represent a more specialized regulatory mechanism
that selectively targets certain cell types. The period
encompassing stages 12 and 13 coincides with numer-
ous significant events in development. In the case of
neuronal differentiation, primary neuronal precursors
undergo their final round of DNA replication (stage
12), the transcript for neuronal signaling molecule X-
Delta-1 becomes expressed in prospective neurons
(stage 12), and the gene for neuron-specific type-II
,3-tubulin is turned on in scattered cells in the neural
plate (stage 12.5-13) (Hartenstein, 1989; Chitnis et al.,
1995). Clearly, it will be highly important to localize
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the p28 mRNA and protein by in situ methods to
delineate precisely the developmental events that
might be related to the up-regulation of p28. In any
case, it appears likely that p28, like p21, p27, and p57,
may play a role in cellular differentiation. The target of
p28 in later embryos has not been established, but
cyclin D, the presumed somatic form of cyclin E, or the
recently described somatic cyclin A2 are potential can-
didates (Howe et al., 1995; Rempel et al., 1995).
In summary, we have identified Xenopus p28, a new
member of the p21/p27 class of Cdk inhibitors. In
vitro, p28 inhibits pre-activated Cdk2/cyclin E and
Cdk2/cyclin A, and prevents CAK-mediated activa-
tion of Cdc2/cyclin B. In Xenopus egg extracts, exog-
enously added p28 inhibits both DNA replication and
mitosis. Finally, the level of p28 protein is up-regu-
lated dramatically during stages 12 and 13, which
temporally correlates with the earliest events in neural
differentiation. In concert with other transitions such
as the replacement of embryonic Cdks with somatic
Cdks, p28 could play an important role in regulating
the somatic cell cycle. Further study of p28 will help us
to gain more insight into cell cycle regulation and its
connection with developmental regulation.
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